Last reviewed · How we verify
NCT06967584
Kinesiotaping on HP Patients Pulmonary Parameters
NA trial testing Kinesio Taping in Hemiplegic Patients in 30 participants. Completed in 23 July 2025.
23 July 2025
Quick facts
| Lead sponsor | Istinye University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 11 November 2024 |
| Primary completion | 23 July 2025 |
| Estimated completion | 23 July 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Kinesio Taping
- Sham Kinesio Taping
Conditions studied
- Hemiplegic Patients — all drugs for Hemiplegic Patients →
- Hemiplegia — all drugs for Hemiplegia →
Sponsor
Istinye University
Who can join
Adults 45 to 80, any sex, with Hemiplegic Patients or Hemiplegia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate whether thoracic kinesio taping contributes to the improvement of pulmonary function, the strengthening of respiratory muscles and the enhancement of overall physical ability in stroke patients with hemiplegia. To assess this, a randomized controlled trial will be conducted involving 30 patients aged between 45 and 80 years who have been diagnosed with hemiplegia resulting from a stroke. Participants will be randomly assigned to one of two groups: the Kinesio Taping Group (KTG) or the Sham Kinesio Taping Group (SKTG). The duration of the intervention will be four weeks. During this period, individuals in the KTG will receive thoracic kinesio taping in addition to standard rehabilitation care. In the SKTG, taping will be applied to the same thoracic area but without tension. Measurements will be obtained both before and after the intervention. These assessments will include pulmonary function tests (such as forced vital capacity and forced expiratory volume), evaluations of respiratory muscle strength (specifically maximum inspiratory pressure), and assessments of functional capacity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06967584
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Kinesio Taping
Trials testing the same drug.
- NCT07464795 — The Effects of Kinesio Taping on Heel-Rise Endurance and Gastrocnemius Muscle Oxygenation in Healthy Young Adults · NA · not yet recruiting
- NCT07515183 — Placebo Effect of Immediate Kinesio Taping on Upper Extremity Performance in Healthy Adults · NA · not yet recruiting
- NCT07404917 — Kinesio Taping for Lacertus Syndrome · NA · not yet recruiting
- NCT07404215 — Comparative Effects of Kinesio and Dynamic Taping on Ankle Performance in Basketball Players · NA · not yet recruiting
- NCT07428083 — Effect of Kinesio Taping Combined With Schroth Therapy in Young Adults With Idiopathic Scoliosis · NA · not yet recruiting
Other Istinye University trials
Trials by the same sponsor.
- NCT06963294 — Ketamine and Dexmedetomidine for Delirium in Joint Arthroplasty · NA · not yet recruiting
- NCT07528807 — Exercise, Pain Beliefs, and Activity Patterns in Musculoskeletal Pain · not yet recruiting
- NCT07520981 — Functional Capacity, Subjective Dyspnea and Fatigue in Smokers · not yet recruiting
- NCT07518095 — Serum Bicarbonate and Enteral Feeding Intolerance in Adult ICU: A Prospective Clinical Trial · not yet recruiting
- NCT07483190 — Effectiveness of Thoracoabdominal Nerve Block (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06967584 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istinye University
- Last refreshed: 25 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06967584.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing